Semaglutide na Tirzepatide ni imiti ibiri ishingiye kuri GLP-1 ikoreshwa mu kuvura diyabete yo mu bwoko bwa 2 n'umubyibuho ukabije.
Semaglutide yerekanye ingaruka nziza mukugabanya urwego rwa HbA1c no guteza imbere kugabanya ibiro. Tirzepatide, igitabo gishya cya GIP / GLP-1 reseptor agonist, nacyo cyemejwe na FDA yo muri Amerika ndetse na EMA yo mu Burayi kuvura diyabete yo mu bwoko bwa 2.
Ingaruka
Semaglutide na tirzepatide byombi birashobora kugabanya cyane urugero rwa HbA1c ku barwayi barwaye diyabete yo mu bwoko bwa 2, bityo bigatuma glucose igenzura neza.
Kubijyanye no kugabanya ibiro, tirzepatide muri rusange yerekana ibisubizo byiza ugereranije na semaglutide.
Ibyago byumutima
Semaglutide yerekanye inyungu z'umutima n'imitsi mu igeragezwa rya SUSTAIN-6, harimo kugabanya ibyago byo gupfa k'umutima n'imitsi, infirasiyo ya myocardial idapfa, ndetse n'indwara idakira.
Ingaruka z'umutima n'imitsi ya Tirzepatide bisaba ubushakashatsi bwimbitse, cyane cyane ibisubizo bivuye mu igeragezwa rya SURPASS-CVOT.
Kwemeza ibiyobyabwenge
Semaglutide yemejwe nk'umugereka w'imirire n'imyitozo ngororamubiri hagamijwe kunoza isukari mu maraso ku bantu bakuze barwaye diyabete yo mu bwoko bwa 2, no kugabanya ibyago byo kwandura indwara zikomeye z'umutima n'imitsi ku bantu bakuze barwaye diyabete yo mu bwoko bwa 2 ndetse n'indwara zifata umutima.
Tirzepatide yemerewe nk'umugereka w'imirire yagabanijwe na calorie no kongera imyitozo ngororamubiri yo gucunga ibiro bidakira ku bantu bakuze bafite umubyibuho ukabije cyangwa umubyibuho ukabije ndetse byibura nibibazo bifitanye isano n'uburemere.
Ubuyobozi
Semaglutide na tirzepatide byombi bitangwa hakoreshejwe inshinge zidasanzwe.
Semaglutide nayo ifite formulaire iboneka.
Igihe cyo kohereza: Nyakanga-08-2025
